• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.

作者信息

Labenz Christian, Schattenberg Jörn M

机构信息

Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.

出版信息

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.

DOI:10.1111/apt.15040
PMID:30488630
Abstract
摘要

相似文献

1
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.编者按：非酒精性脂肪性肝病患者F3和F4的逐步风险分层——作者回复
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.
2
Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patients.社论：非酒精性脂肪性肝病（NAFLD）患者F3和F4纤维化阶段的逐步风险分层
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1317-1318. doi: 10.1111/apt.15024.
3
Leukocyte extracellular vesicle concentration is inversely associated with liver fibrosis severity in NAFLD.非酒精性脂肪性肝病患者白细胞细胞外囊泡浓度与肝纤维化严重程度呈负相关。
J Leukoc Biol. 2018 Sep;104(3):631-639. doi: 10.1002/JLB.5A1217-501R. Epub 2018 Mar 30.
4
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.社论：重新审视非酒精性脂肪性肝病合并晚期纤维化时的心血管危险因素？作者回复。
Aliment Pharmacol Ther. 2020 May;51(10):988-989. doi: 10.1111/apt.15696.
5
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
6
Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply.
Aliment Pharmacol Ther. 2020 Mar;51(6):662-663. doi: 10.1111/apt.15651.
7
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.纤维化分期而非 NASH 可预测经活检证实的非酒精性脂肪性肝病患者的死亡率和严重肝脏疾病的发生时间。
J Hepatol. 2017 Dec;67(6):1265-1273. doi: 10.1016/j.jhep.2017.07.027. Epub 2017 Aug 10.
8
A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.FibroMeter™非酒精性脂肪性肝病评分、非酒精性脂肪性肝病纤维化评分及瞬时弹性成像作为经活检证实的非酒精性脂肪性肝病患者肝纤维化无创诊断工具的比较
Scand J Gastroenterol. 2014 Nov;49(11):1343-8. doi: 10.3109/00365521.2014.958099. Epub 2014 Sep 26.
9
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply.社论：在现实世界中，非酒精性脂肪性肝病有多普遍和严重？作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(11):1200-1201. doi: 10.1111/apt.15724.
10
Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.红细胞分布宽度与血小板比值和无创纤维化评分在经活检证实的非酒精性脂肪性肝病肝纤维化诊断中的比较诊断准确性
Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1293-9. doi: 10.1097/MEG.0000000000000445.